Research ExplorerScientific StaffFlorian Langer Publications

Prof. Dr. med. ID: 60903

Florian Langer

graph of relations
Affiliations
101 - 123 out of 123Page size: 50

Publications

  1. 2014

  2. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion

    Langer, F., Obser, T., Oyen, F., Spath, B., Holstein, K., Greinacher, A., White, J. G., Budde, U., Bokemeyer, C. & Schneppenheim, R., 01.04.2014, In: THROMB HAEMOSTASIS. 111, 4, p. 777-779 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation

    Langer, F. & Ruf, W., 01.04.2014, In: THROMB HAEMOSTASIS. 111, 4, p. 590-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor

    Holstein, K., Schneppenheim, R., Schrum, J., Bokemeyer, C. & Langer, F., 01.01.2014, In: HAMOSTASEOLOGIE. 34 , 4A, p. 5-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Bridging: Perioperatives Vorgehen bei dauerhafter oraler Antikoagulation oder Plättchenfunktionshemmung

    Nowak-Göttl, U., Langer, F., Limperger, V., Mesters, R. & Trappe, R. U., 2014, In: DEUT MED WOCHENSCHR. 139, 24, p. 1301-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2013

  7. Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses

    Amirkhosravi, A., Bigsby, G., Desai, H., Rivera-Amaya, M., Coll, E., Robles-Carrillo, L., Faust, P., Waters, A., Meyer, T., Reyes, E., Langer, F. & Francis, J. L., 01.07.2013, In: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 24, 5, p. 510-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase

    Langer, F., Spath, B., Fischer, C., Stolz, M., Ayuketang, F. A., Kröger, N-M., Bokemeyer, C. & Ruf, W., 21.03.2013, In: BLOOD. 121, 12, p. 2324-35 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Relevant bleeding diathesis due to acquired factor XIII deficiency

    Janning, M., Holstein, K., Spath, B., Schnabel, C., Bannas, P., Bokemeyer, C. & Langer, F., 01.01.2013, In: HAMOSTASEOLOGIE. 33 Suppl 1, p. S50-4

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy

    Honecker, F., Koychev, D., Lühmann, A. D., Langer, F., Dieckmann, K-P., Bokemeyer, C. & Oechsle, K., 01.01.2013, In: ONKOLOGIE. 36, 11, p. 663-8 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Perioperative thromboprophylaxis

    Langer, F., 2013, In: VISZERALMEDIZIN. 29, 5, p. 297-302

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 2012

  13. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.

    Langer, F. & Bokemeyer, C., 2012, In: HAMOSTASEOLOGIE. 32, 2, p. 95-104 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.

    Holstein, K., Marx, G., Lentz, B., Bokemeyer, C. & Langer, F., 2012, In: HAMOSTASEOLOGIE. 32 Suppl 1, p. 48-51

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.

    Spath, B., Hansen, A., Bokemeyer, C. & Langer, F., 2012, In: PLATELETS. 23, 1, p. 60-68 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. 2011

  17. Akute Blutungen ohne Trauma - Gerinnung checken mit System

    Langer, F., Holstein, K. & Bokemeyer, C., 2011, In: Der Allgemeinarzt. 33, 15, p. 37-40 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. [Venous thrombembolism in tumour patients].

    Pabinger, I., Alt-Epping, B., Demarmels Biasutti, F., Langer, F., Wörmann, B. & Riess, H., 2011, In: HAMOSTASEOLOGIE. 31, 4, p. 281-282 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2010

  20. Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice.

    Robles-Carrillo, L., Meyer, T., Hatfield, M., Desai, H., Dávila, M., Langer, F., Amaya, M., Garber, E., Francis, J. L., Hsu, Y-M. & Amirkhosravi, A., 2010, In: J IMMUNOL. 185, 3, p. 1577-1583 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2009

  22. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice.

    Meyer, T., Robles-Carrillo, L., Robson, T., Langer, F., Desai, H., Davila, M., Amaya, M., Francis, J. L. & Amirkhosravi, A., 2009, In: J THROMB HAEMOST. 7, 1, p. 171-181 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Deficiencies in the CD40 and CD154 receptor-ligand system reduce experimental lung metastasis.

    Ingersoll, S. B., Langer, F., Walker, J. M., Meyer, T., Robson, T., Amaya, M., Desai, H., Francis, J. L. & Amirkhosravi, A., 2009, In: CLIN EXP METASTAS. 26, 7, p. 829-837 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Thromboembolische Komplikationen - Prophylaxe und Therapie im Fokus

    Langer, F., Holstein, K., Eifrig, B. & Bokemeyer, C., 2009, In: ONKOLOGE. 15, p. 150-156

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.

    Haubold, K., Rink, M., Spath, B., Friedrich, M., Chun, F., Marx, G., Amirkhosravi, A., Francis, J. L., Bokemeyer, C., Eifrig, B. & Langer, F., 2009, In: THROMB HAEMOSTASIS. 101, 6, p. 1147-1155 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2008

  27. A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin.

    Gerdsen, F., Luxembourg, B., Langer, F., Bauersachs, R. & Lindhoff-Last, E., 2008, In: BLOOD COAGUL FIBRIN. 19, 6, p. 477-481 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. [Haemostatic aspects in clinical oncology]

    Langer, F., Holstein, K., Eifrig, B. & Bokemeyer, C., 2008, In: HAMOSTASEOLOGIE. 28, 5, p. 472-480 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.

    Langer, F., Spath, B., Haubold, K., Holstein, K., Marx, G., Wierecky, J., Brümmendorf, T., Dierlamm, J., Bokemeyer, C. & Eifrig, B., 2008, In: ANN HEMATOL. 87, 6, p. 451-457 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 2007

  31. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.

    Langer, F., Chun, F., Amirkhosravi, A., Friedrich, M., Leuenroth, S., Eifrig, B., Bokemeyer, C. & Francis, J. L., 2007, In: THROMB HAEMOSTASIS. 97, 3, p. 464-470 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next